# HepaRegeniX funding: rounds and investors > HepaRegeniX has raised $34M across 2 rounds since 2017. Investors include Novo Holdings, Wellington Partners and Boehringer Ingelheim Venture Fund. Source: https://millionrounds.com/company/heparegenix (Millionrounds; every figure on the page links to its filing or article) Germany · [Venture startup](https://millionrounds.com/companies) # Who invested in *HepaRegeniX* 2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$34M** raised across 2 rounds since 2017, from 2 sources **$9.5M** Series A **$24M** Venture - **Latest round:** Venture, $24M Apr 2025 - **Step-up i:** 2.6× - **Investors:** 5 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2017 2019 2021 2023 2025 **$9.5M** Series A **$24M** Venture - **First round:** Series A, $9.5M - **Biggest round:** $24M - **Between rounds:** 8.3 years ## The rounds - **Apr 2025** Venture **$24M** *3 new* [Novo Holdings](https://millionrounds.com/fund/novo-ventures) [Wellington Partners](https://millionrounds.com/fund/wellington-partners) [Boehringer Ingelheim Venture Fund](https://millionrounds.com/fund/boehringer-ingelheim-venture-fund) Source recorded - **Jan 2017** Series A **$9.5M** *2 new* [Boehringer Ingelheim](https://millionrounds.com/fund/boehringer-ingelheim) [Novo Seeds](https://millionrounds.com/fund/novo-seeds) Reported by FinSMEs ## Founders and team From HepaRegeniX's own website: 13 on the team. - **Elias Papatheodorou** Chief Executive Officer - **Christoph Enderle** Chief Financial Officer - **Dr. Linda Greenbaum** Chief Medical Officer - **Dr. Wolfgang Albrecht** Chief Operating Officer - **Dr. Emmanuelle Coutanceau** Board Member / Novo Holdings A/S - **Dr. Fabienne Roussel** Board Member / Vesalius Biocapital - **Dr. Frank Hensel** Board Member / High-Tech Gründerfonds (HTGF) - **Dr. Manuel Baader** Board Member / Boehringer Ingelheim Venture Fund - **Dr. Martin Bonde** Chair of the Board - **Dr. Roland Selig** Lead Medicinal and Process Chemistry - **Dr. Tillmann Taube** Senior Medical Director - **Hedda Wold** Lead Clinical Operations - **Stefan Zwirner** Lead In vitro Pharmacology ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2017 **Venture** 2025 [Novo Holdings](https://millionrounds.com/fund/novo-ventures) [Wellington Partners](https://millionrounds.com/fund/wellington-partners) [Boehringer Ingelheim Venture Fund](https://millionrounds.com/fund/boehringer-ingelheim-venture-fund) [Boehringer Ingelheim](https://millionrounds.com/fund/boehringer-ingelheim) [Novo Seeds](https://millionrounds.com/fund/novo-seeds) ## Everyone who backed them [Novo Holdings](https://millionrounds.com/fund/novo-ventures) VC firm **1** round [Wellington Partners](https://millionrounds.com/fund/wellington-partners) VC firm **1** round [Boehringer Ingelheim Venture Fund](https://millionrounds.com/fund/boehringer-ingelheim-venture-fund) Corporate VC **1** round [Boehringer Ingelheim](https://millionrounds.com/fund/boehringer-ingelheim) VC firm **1** round [Novo Seeds](https://millionrounds.com/fund/novo-seeds) VC firm **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=heparegenix). ## Quick answers about HepaRegeniX ### Who invested in HepaRegeniX? HepaRegeniX's investors include Novo Holdings, Wellington Partners, Boehringer Ingelheim Venture Fund, Boehringer Ingelheim and Novo Seeds. ### How much has HepaRegeniX raised? HepaRegeniX has raised $34M across 2 rounds since 2017. ### When did HepaRegeniX last raise? HepaRegeniX's most recent round was a Venture of $24M in Apr 2025. ### What was HepaRegeniX's biggest round? Its most recent round, $24M in Apr 2025, is also its largest on record. ### Who backed HepaRegeniX first? HepaRegeniX's first round on record, in Jan 2017, was backed by Boehringer Ingelheim and Novo Seeds. ### What stage is HepaRegeniX at? HepaRegeniX's latest named round is a Venture, in Apr 2025. ### Where is HepaRegeniX based? HepaRegeniX is based in Germany. ## Companies like HepaRegeniX In the same sector, and raised in the last eighteen months. [**Cellbox Solutions** $4.1M · Oct 2026](https://millionrounds.com/company/cellbox-solutions)[**ViferaXS** $14M · Sept 2026](https://millionrounds.com/company/viferaxs)[**Arab Therapy** $2.0M · Aug 2026](https://millionrounds.com/company/arab-therapy)[**Pentixapharm** $40M · Jul 2026](https://millionrounds.com/company/pentixapharm)[**Pacifico Biolabs** $11M · Jul 2026](https://millionrounds.com/company/pacifico-biolabs)[**smartbax** $5.5M · Jun 2026](https://millionrounds.com/company/smartbax) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app